Dexmedetomidine Versus Magnesium Infusion in Reducing Agitations in Pediatric Patients Undergoing Adenotonsillectomy

• Status: Active, not recruiting
• Trial end date: 2022-12-07
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is evaluating the efficacy and safety of dexmedetomidine versus Magnesium for reducing emergence agitation after adenotonsillectomy in children.

Secondary outcome is to reduce child needs for analgesics and to reduce their dose.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ain Shams University
• Treatments: Dexmedetomidine; Magnesium Sulfate

Criteria

Inclusion Criteria:

• ASA I or II.

• Age group: 4-12 years old.

• The procedure expected to be completed within 1 hour.

Exclusion Criteria:

• Patients with expected difficult airway management.

• lack of consent.

• known adverse effects to dexmedetomidine.

• Mental retardation developmental delay, or neurological or psychiatric illness that may associate with agitation (cerebral palsy, seizure..etc.)

• Hemodynamically unstable patients.

• Persistent cough or high airway secretions.

• Clinical signs of active infectious disease.

• Coagulopathy (INR >1.5).

• Obesity (BMI >30 Kg/m2 ).

• Surgical complication